Partha Chowdhury is Senior Director in Sanofi Biologics Research, US. He joined Sanofi in 2017 and leads antibody discovery and technology development activities in Biologics discovery, research and development. He has been involved with antibody discovery, engineering and technology development for the last 20 years.
Partha did his Ph.D. dissertation in biochemistry from the Indian Institute of Chemical Biology and his post-doctoral research in NIH. During this time and in his tenure at the Human Genome Sciences and MedImmune, he has discovered and developed several different platforms for antibody discovery and engineering, many of which have led to awarded patents. Partha is a recipient of Excellence in Technology Transfer, awarded by the US National Laboratory Consortium. He serves in the editorial board of mAbs and is an author of many peer reviewed publications and patents.
Conference 29 - 31 October • Exhibition & Seminars 29 - 31 October
To sponsor or exhibit contact:
Derek Cavanagh
+44 (0)207 092 1297
derek.cavanagh@terrapinn.com
To speak:
Joan Shutt
+44 (0)207 092 1134
joan.shutt@terrapinn.com